THE SELECT-1 STUDY DESIGN: SELUMETINIB IN COMBINATION WITH DOCETAXEL FOR SECOND-LINE TREATMENT OF KRAS MUTATION-POSITIVE LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER

作者: Pasi A Jaenne , Helen Mann , Ian Smith

DOI:

关键词:

摘要:

参考文章(0)